| Title |
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors
|
|---|---|
| Published in |
Investigational New Drugs, September 2010
|
| DOI | 10.1007/s10637-010-9541-0 |
| Pubmed ID | |
| Authors |
Matthew D. Galsky, Daniel D. Von Hoff, Marcus Neubauer, Thomas Anderson, Mark Fleming, Yasir Nagarwala, Janine M. Mahoney, Dawn Midwinter, Linda Vocila, Tal Z. Zaks |
| Abstract |
To explore the activity of lapatinib with a novel trial design focused on the drug target rather than on histology. |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 3% |
| Switzerland | 1 | 1% |
| Unknown | 66 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 22% |
| Student > Master | 9 | 13% |
| Student > Ph. D. Student | 9 | 13% |
| Student > Bachelor | 4 | 6% |
| Student > Doctoral Student | 4 | 6% |
| Other | 12 | 17% |
| Unknown | 16 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 43% |
| Agricultural and Biological Sciences | 7 | 10% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Psychology | 2 | 3% |
| Other | 5 | 7% |
| Unknown | 19 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2011.
All research outputs
#7,454,298
of 22,789,076 outputs
Outputs from Investigational New Drugs
#324
of 1,168 outputs
Outputs of similar age
#34,679
of 96,976 outputs
Outputs of similar age from Investigational New Drugs
#7
of 23 outputs
Altmetric has tracked 22,789,076 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,168 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,976 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.